Early evaluation of opportunities in oral delivery of PROTACs to overcome their molecular challenges

被引：7
|
作者：
Yang, Wenzhan [1 ]
Saboo, Sugandha [1 ]
Zhou, Liping [1 ]
Askin, Sean [2 ]
Bak, Annette [1 ]
机构：
[1] AstraZeneca, Adv Drug Delivery, Pharmaceut Sci, R&D, Boston, MA 02451 USA
[2] AstraZeneca, Adv Drug Delivery, Pharmaceut Sci, R&D, Cambridge, England
来源：
DRUG DISCOVERY TODAY | 2024年 / 29卷 / 02期
关键词：
drug delivery; PROTAC; drug discovery; lipid-based formulations (LBF); amorphous solid dispersions (ASDs); LIPID-BASED FORMULATIONS; WATER-SOLUBLE DRUGS; PRECIPITATION INHIBITORS; CYCLOSPORINE-A; SYSTEMS; ABSORPTION; BIOAVAILABILITY; CLASSIFICATION; SOLUBILITY; PERMEABILITY;
D O I：
10.1016/j.drudis.2023.103865
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PROteolysis TArgeting Chimeras (PROTACs) offer new opportunities in modern medicine by targeting proteins that are intractable to classic inhibitors. Heterobifunctional in nature, PROTACs are small molecules that offer a unique mechanism of protein degradation by hijacking the ubiquitin-mediated protein degradation pathway, known as the ubiquitin-proteasome system. Herein, we present an analysis on the structural characteristics of this novel chemical modality. Furthermore, we review and discuss the formulation opportunities to overcome the oral delivery challenges of PROTACs in drug discovery.
引用
收藏
页数：12
相关论文
共 50 条
  • [21] Roadmapping: (Missed) opportunities to overcome strategic challenges
    Siebelink, Remco
    Hofman, Erwin
    Halman, Johannes I. M.
    Nee, Ingo
    BUSINESS HORIZONS, 2021, 64 (04) : 501 - 512
  • [22] Small-Molecule Degraders beyond PROTACs-Challenges and Opportunities
    Kastl, Johanna M.
    Davies, Gareth
    Godsman, Eleanor
    Holdgate, Geoffrey A.
    SLAS DISCOVERY, 2021, 26 (04) : 524 - 533
  • [23] Opportunities and challenges in vaccine delivery
    Carstens, Myrra G.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 36 (4-5) : 605 - 608
  • [24] Challenges and opportunities of MAbs delivery
    Hwang, Robin
    Yang, Tzung
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [25] Rationale for faster oral delivery to overcome the pathophysiology associated with dental pain — Biopharmaceutic and pharmacokinetic challenges
    Nuggehally R. Srinivas
    European Journal of Drug Metabolism and Pharmacokinetics, 2009, 34 : 7 - 10
  • [26] Rationale for faster oral delivery to overcome the pathophysiology associated with dental pain - Biopharmaceutic and pharmacokinetic challenges
    Srinivas, Nuggehally R.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2009, 34 (01) : 7 - 10
  • [27] Drug delivery challenges and formulation aspects of proteolysis targeting chimera (PROTACs)
    Saraswat, Aishwarya L.
    Vartak, Richa
    Hegazy, Rehab
    Patel, Akanksha
    Patel, Ketan
    DRUG DISCOVERY TODAY, 2023, 28 (01) : 1 - 9
  • [28] Oral Nanomedicine: Challenges and Opportunities
    Deng, Bo
    Liu, Shaomin
    Wang, Ying
    Ali, Barkat
    Kong, Na
    Xie, Tian
    Koo, Seyoung
    Ouyang, Jiang
    Tao, Wei
    ADVANCED MATERIALS, 2024, 36 (06)
  • [29] Opportunities and challenges in oral therapy
    J Rajfer
    International Journal of Impotence Research, 2000, 12 : S59 - S61
  • [30] Opportunities and challenges in oral therapy
    Rajfer, J
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2000, 12 (Suppl 4) : S59 - S61
12345